<SEC-DOCUMENT>0001564590-16-015008-index.html : 20160318
<SEC-HEADER>0001564590-16-015008.hdr.sgml : 20160318
<ACCEPTANCE-DATETIME>20160317181743
ACCESSION NUMBER:		0001564590-16-015008
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20160318
DATE AS OF CHANGE:		20160317
EFFECTIVENESS DATE:		20160318

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cidara Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001610618
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				461537286
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-210263
		FILM NUMBER:		161513598

	BUSINESS ADDRESS:	
		STREET 1:		6310 NANCY RIDGE DRIVE
		STREET 2:		SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-752-6170

	MAIL ADDRESS:	
		STREET 1:		6310 NANCY RIDGE DRIVE
		STREET 2:		SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	K2 THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20140611
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>cdtx-s8_20160317.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: cdtx-s8_20160317.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>cdtx-ex51_120.htm
<DESCRIPTION>EX-5.1 OPINION OF COOLEY LLP
<TEXT>
Document 2 - file: cdtx-ex51_120.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>cdtx-ex231_7.htm
<DESCRIPTION>EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
Document 3 - file: cdtx-ex231_7.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g2016031719304239312719.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: g2016031719304239312719.jpg

</DOCUMENT>
</SEC-DOCUMENT>